4th Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part B Reimbursement. Average Sales Price (ASP). Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477). Inflation Reduction Act. Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages. Part B drug pricing changes. Enhanced Oncology Model (EOM).

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2764 (118th), H.R. 1770 (118th), S. 2477 (118th), S. 1491 (118th), S. 3458 (118th), H.R. 5526 (118th)

Pharmacy PHA

Legislation to provide for coverage under Medicare program for pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act (S.1491). House and Senate Agriculture, FDA, and related agency Appropriations bills. House and Senate Labor/HHS appropriations bills. Prescription drug importation. Issues and policies related to generic drug shortages. The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477).

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS New —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1491 (118th), S. 2477 (118th), H.R. 1770 (118th)

Health Issues HCR

Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Ensuring essential medication supply for military and Department of Defense. Digital communication of prescribing information. Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages. Block, Report and Suspend Suspicious Shipments Act (H.R.501). Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S. 2510). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY 2024 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 2916 (118th), H.R. 501 (118th), H.R. 1503 (118th), H.R. 405 (118th), S. 2433 (118th), H.R. 4531 (118th), S. 2510 (118th)

Taxation/Internal Revenue Code TAX

Tax Cuts and Jobs Act of 2017. LIFO accounting method. U.S. corporate tax rate.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.